MedTrace Logo

Feasibility and Acceptability of Butterfly iQ

NCT05054504 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1575

Last updated 2024-04-09

No results posted yet for this study

Summary

The purpose of this study is to investigate feasibility and acceptability of a novel intervention to integrate Butterfly IQ into antenatal care (ANC) service delivery in Malawi. The study will also explore potential impact of the intervention on selected service delivery outcomes and identification of abnormal pregnancies.

Conditions

  • Pregnancy Related

Interventions

DEVICE

Butterfly iQ

The primary intervention under study is the Butterfly iQ point-of-care ultrasound device, embedded in a larger program of training, iterative ANC service delivery design, and a final program evaluation.

Sponsors & Collaborators

  • Bill and Melinda Gates Foundation

    collaborator OTHER

  • Johns Hopkins Bloomberg School of Public Health

    collaborator OTHER

  • Kamuzu University of Health Sciences

    collaborator OTHER

  • Ministry of Health, Malawi

    collaborator OTHER_GOV

  • Jhpiego

    lead OTHER

Principal Investigators

  • Lisa M Noguchi, PhD, MSN · Jhpiego, Johns Hopkins University

  • Linly Seyama · University of Malawi College of Medicine, JHP Blantyre

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-10-06
Primary Completion
2024-03-15
Completion
2024-03-15
FDA Device
Yes

Countries

  • Malawi

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05054504 on ClinicalTrials.gov